Broad goals are to define the mechanisms of blood clotting by Staphylococcus aureus staphylocoagulase (SC) and von Willebrand factor binding-protein (vWbp), and their roles in acute infective endocarditis (AIE). Endothelial damage on heart valves activates coagulation and concurrent S. aureus bacteremia allows bacteria to bind to the injury site. SC/vWbp activate host prothrombin (ProT) non-proteolytically by inserting their N-termini into a cleft in ProT. Active SC/vWbp.ProT* complexes cleave fibrinogen (Fbg) to fibrin (Fbn), aiding growth of platelet-Fbn-bacteria vegetations. S. aureus AIE is 25-47% fatal despite antibiotic therapy. Due to rapid spread of hypervirulent, multidrug-resistant strains, S. aureus wil likely become resistant to all antibiotics and a huge threat to public health. Drug companies are reluctant to develop new antibiotics due to low profitability, exacerbating the threat.
Aim 1 will define the specificity of ProT for insertion of the SC N-terminus. The 3 N-terminal residues are hypothesized to dictate affinity and activity of SC.ProT*. Virtual screening of 3- residue combinations will select the highest affinity for evaluation in 3 contexts: SC, vWbp, and meizothrombin.
Aim 1 answers the question: Does the conservation of Ile-Val and Val- Val N-termini in serine proteinases reflect the strict specificity of the binding cleft, or are there resdue combinations with higher affinity? SC results show that the ProT cleft accepts diverse residues, some producing higher activity than wild-type. Likely outcomes are that activity and affinity are context-dependent and the bases for the differences will be defined. An anti-SC(1-10) mAb inhibits ProT activation with nM affinity, increases survival in a sepsis model, and supports the potential to develop mAb therapeutics for AIE.
Aim 2 will define the binding and activation pathway of ProT by SC and Fbg binding to SC.ProT*. Rapid-reaction kinetics will access millisecond-second time-scales on which these events occur. Outcomes will identify the activation step for ProT and the step of Fbg substrate engagement.
Aim 3 will decipher the roles of the disordered C-terminal pseudo-repeat and seven, 27-residue SC repeats in binding fibrin(ogen) and fragment D. Binding sites on the repeat sequences and fragment D will be mapped by crosslinking. Fbg binding and cleavage kinetics will test if the repeats assist Fbg binding through a (SC.ProT*)2.Fbg complex. Anti-repeat mAbs will be evaluated in vitro and in vivo.
Aim 4 tests the idea that SfbX and ZAAP4 activate ProT by N- terminal insertion and will discover the substrates and adhesion proteins of the SfbX/ZAAP4.(pro)thrombin* complexes, providing insight into their roles in pathogenesis.

Public Health Relevance

Staph infections range from common, minor skin infections to blood-borne infections of the heart valves called infective endocarditis. The proposed research project focuses on the roles of two proteins secreted by staph called coagulases in endocarditis on the molecular level, with the goal of developing new monoclonal antibody inhibitors of coagulases for treatment of endocarditis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL071544-12
Application #
8707836
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Sarkar, Rita
Project Start
2003-01-01
Project End
2017-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
12
Fiscal Year
2014
Total Cost
$380,436
Indirect Cost
$124,852
Name
Vanderbilt University Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Baaten, Constance C F M J; Swieringa, Frauke; Misztal, Tomasz et al. (2018) Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects. Blood Adv 2:2320-2331
Voehler, Markus; Ashoka, Maddur Appajaiah; Meiler, Jens et al. (2017) Carbon and amide detect backbone assignment methods of a novel repeat protein from the staphylocoagulase in S. aureus. Biomol NMR Assign 11:243-249
Davis 4th, Richard W; Brannen, Andrew D; Hossain, Mohammad J et al. (2016) Complete genome of Staphylococcus aureus Tager 104 provides evidence of its relation to modern systemic hospital-acquired strains. BMC Genomics 17:179
Davis 4th, Richard W; Eggleston, Heather; Johnson, Frances et al. (2015) In Vivo Tracking of Streptococcal Infections of Subcutaneous Origin in a Murine Model. Mol Imaging Biol 17:793-801
Verhamme, I M; Panizzi, P R; Bock, P E (2015) Pathogen activators of plasminogen. J Thromb Haemost 13 Suppl 1:S106-14
Davis, Richard; Hossain, Mohammad J; Liles, Mark R et al. (2013) Complete Genome Sequence of Staphylococcus aureus Tager 104, a Sequence Type 49 Ancestor. Genome Announc 1:
Munnix, Imke C A; Kuijpers, Marijke J E; Auger, Jocelyn et al. (2007) Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol 27:2484-90
Bianchini, Elsa P; Orcutt, Steven J; Panizzi, Peter et al. (2005) Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase. Proc Natl Acad Sci U S A 102:10099-104